Welcome to our dedicated page for Teladoc Health news (Ticker: TDOC), a resource for investors and traders seeking the latest updates and insights on Teladoc Health stock.
Teladoc Health reports news on its virtual care business, including financial results, segment performance, product innovation, technology investment, and governance updates. The company delivers and orchestrates care across patients, care providers, platforms, and partners through relationships with health plans, employers, providers, health systems, and consumers.
Recurring updates focus on Integrated Care, which includes virtual care solutions such as primary care, mental health, chronic care management, and telehealth enablement, and BetterHelp, the company’s direct-to-consumer online mental health offering. Company news also includes earnings calls, investor conference participation, board appointments and retirements, inducement equity awards, and strategic commentary on its clinical model and care-delivery platform.
Teladoc Health (NYSE: TDOC), a leader in virtual care, announced executives Jason Gorevic and Mala Murthy will present at the William Blair 40th Annual Growth Stock Conference on June 9, 2020, at 1:00 p.m. EDT. The event will feature a live audio webcast and replay accessible through their investor relations website. Teladoc Health focuses on high-quality, cost-effective healthcare solutions, recognized as the top telehealth provider in the J.D. Power 2019 U.S. Telehealth Satisfaction Study. With over 2,400 employees, it operates in 175 countries, improving healthcare access and outcomes globally.
Teladoc Health (NYSE: TDOC) announced a pricing increase for its offering of Convertible Senior Notes to $850 million, up from the previously stated $800 million. The offering, set to close on May 19, 2020, includes an option for initial purchasers to buy an additional $150 million. The estimated net proceeds are about $829 million, intended for exchanging existing debt, working capital, and general corporate purposes. The Notes will bear a 1.25% annual interest, maturing in 2027, and are convertible under certain conditions. The offering is private and not registered under the Securities Act.
Teladoc Health announced its intention to offer $800 million in Convertible Senior Notes due 2027, with an option for an additional $120 million. Proceeds will be used to exchange existing 2022 Convertible Notes for cash and shares, and also for general corporate purposes, including debt repayment and potential acquisitions. The unsecured notes will pay interest semiannually, with various conversion rights structured into the agreement. The offering will comply with Rule 144A of the Securities Act and is aimed at qualified institutional buyers.